A practical reference on molecular weight: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2026-07-17. Anything still debated is marked as such rather than presented as settled.
Stability depends on moisture, temperature, and packaging. Dry powders are generally stable for months to years when kept sealed and cool, but heat and humidity can promote clumping, Maillard reactions, and off-flavors. Peptides with lower molecular weight may be more hygroscopic than longer-chain hydrolysates. Light exposure is less critical than moisture control for most commercial powders. Once a container is opened, repeated exposure to air can shorten usable shelf life.
Analytical results are method-dependent, so comparisons across studies require caution. Different molecular weight cutoffs, standards, and calculation models can shift reported averages. Hydroxyproline content is sometimes used as a marker for collagen-derived material, but it does not reveal peptide sequence or biological activity. Regulatory status varies by country and intended use, with some markets treating hydrolyzed collagen as a food ingredient and others as a dietary supplement. Open questions include how to standardize potency and verify claimed peptide profiles.
Quality control for hydrolyzed collagen begins with identity testing and raw material traceability. Laboratories may verify protein content by Kjeldahl or combustion methods, and characterize molecular weight distribution using size-exclusion chromatography or gel electrophoresis. Amino acid analysis confirms the presence of glycine, proline, and hydroxyproline in expected proportions. Moisture, ash, and microbial limits are also monitored because powders can absorb water. These tests help distinguish hydrolyzed collagen from gelatin, whey, or plant protein ingredients.
Quality control for collagen peptides includes measurements of moisture content, ash, protein content, and heavy metals. Microbial limits are set to ensure food or cosmetic grade safety, and the degree of hydrolysis serves as a key process indicator. That indicator correlates with molecular weight distribution and solubility characteristics. Regulatory requirements vary by country, and some jurisdictions restrict label claims about health effects. Documentation such as certificates of analysis and safety data sheets typically accompanies commercial shipments of the material.
Analytical testing of collagen peptides focuses on identity, purity, and molecular weight profile. Size-exclusion chromatography separates peptides by hydrodynamic volume and is often calibrated with known protein standards. Amino acid analysis after acid hydrolysis provides the compositional profile, which can confirm the collagen origin. Mass spectrometry offers detailed sequence information for individual peptides. These methods together help ensure that a product matches its specification and that batch-to-batch variability is controlled.
Dry collagen peptide powder is generally stable when kept in a sealed container away from moisture, heat, and direct sunlight. The powder is hygroscopic and can clump if exposed to humid air, so desiccant packets are sometimes included. In solution, collagen peptides are susceptible to microbial growth unless preserved or refrigerated. Prolonged exposure to high temperatures may cause aggregation or color changes. Typical storage recommendations are cool and dry conditions at ambient temperature.
| Property | Value | Notes |
|---|---|---|
| Storage temperature | 15–25 °C | Cool, dry conditions reduce moisture uptake and clumping. |
| Relative humidity | Below 60% | High humidity can make powder sticky or caked. |
| Moisture content | Typically below 10% | Lower moisture supports longer shelf life. |
| Analytical method | Size-exclusion chromatography | Used to estimate molecular weight distribution. |
| Shelf life | 24–36 months unopened | Varies with packaging, source, and storage conditions. |
=== Parasites === The protozoan parasites that cause the diseases malaria, trypanosomiasis, toxoplasmosis, cryptosporidiosis and leishmaniasis are important human pathogens. Malarial parasites that are resistant to the drugs that are currently available to infections are common and this has led to increased efforts to develop new drugs. Resistance to recently developed drugs such as artemisinin has also been reported. The problem of drug resistance in malaria has driven efforts to develop vaccines. Trypanosomes are parasitic protozoa that cause African trypanosomiasis and Chagas disease (American trypanosomiasis). There are no vaccines to prevent these infections so drugs such as pentamidine and suramin, benznidazole and nifurtimox are used to treat infections. These drugs are effective but infections caused by resistant parasites have been reported. Leishmaniasis is caused by protozoa and is a public health problem in sub-tropical and tropical countries. Drug resistance has "become a major concern". The preferred treatment for leishmaniasis regionally; liposomal amphotericin B is used in the Mediterranean basin and pentavalent antimonials are more commonly used in Africa, South America, Bangladesh, India, and Nepal. Resistance to antibiotics in Leishmania is a relatively recent phenomena. The first reported instance of resistance to antimonials was reported in India in the 1980s.
=== 1950s === In the 1950s, we saw innovation in technology across all fields, but most importantly there were many breakthroughs which led to modern medicine. On 6 March 1953, Dr. Jonas Salk announced the completion of the first successful killed-virus Polio vaccine. The vaccine was tested on about 1.6 million Canadian, American, and Finnish children in 1954. The vaccine was announced as safe on 12 April 1955. The 1950s saw foundational breakthroughs that reshaped modern molecular biology and clinical medicine. In 1953, James Watson and Francis Crick, drawing on the X-ray diffraction work of Rosalind Franklin and Maurice Wilkins, deduced the double-helix structure of DNA. In December 1953 at the Brigham Hospital in Boston, Dr. Joseph Murray performed the first successful human kidney transplant between identical twins. By 1958, Rune Elmqvist and Ake Senning developed and implanted the first fully internal cardiac pacemaker.
=== Pharmacokinetics === Nicomorphine is rapidly metabolized when administered by the I.V. route, having a half-life of 3 minutes, into morphine and 6-nicotinoylmorphine, the secondary active metabolite. Half lives of the metabolites were 3–15 minutes for the nicotinoyl metabolite, and 135–190 minutes for morphine. Via the epidural route, a much slower release from epidural space occurs and nicomorphine remains detectable for 1.5 hours or so, and has a longer effect of 18.2 +/- 10.1 hours due to slower release of the active metabolites, morphine and 6-nicotinoylmorphine. Half lives for those compounds is listed in the IV route. Pharmacokinetics via the rectal route differ, and change metabolism. Eight minutes after administration, morphine appeared rapidly, and had a half life of 1.48 +/- 0.48h. This was in turn metabolized to morphine-3- and morphine-6-glucoranides after another 12 minutes, which had similar half-lives to one-another, at about 2.8h. No 6-mononicotinoylmorphine was found, and bioavailability of morphine and metabolic actives was 88%. No remaining nicomorphine was found in urine.
By August 2020, when only a few vaccine candidates were in Phase III trials and were many months away from establishing safety and efficacy, numerous governments pre-ordered more than 2 billion doses at a cost of more than US$5 billion. Pre-orders from the British government for 2021 were for five vaccine doses per person, a number dispiriting to organizations like the WHO and GAVI which are promoting fair and equitable access worldwide, especially for developing countries. In September, CEPI was financially supporting basic and clinical research for nine vaccine candidates, with nine more in evaluation, under financing commitments to manufacture 2 billion doses of three licensed vaccines by the end of 2021. Before 2022, 7–10 billion COVID‑19 vaccine doses may be manufactured worldwide, but the sizable pre-orders by affluent countries – called "vaccine nationalism" – threaten vaccine availability for poorer nations. The RNA vaccines from Moderna and Pfizer-BioNTech are unusually difficult to produce because they rely upon encapsulation of mRNA in lipid nanoparticles, a novel technology which has never been scaled up before for mass production. As of February 2021, this was thought to be the primary bottleneck in the manufacturing of such vaccines. In November 2021, Moderna CEO Stéphane Bancel claimed that the company had a backlog of tens of millions of doses of its vaccine destined for Africa because COVAX or individual governments could not take delivery. He cited delays with dose administration, a shortage of refrigerator space, and delays getting customs documents.
Interest in the collective's work gave rise to an artistic movement referred to as the Rogue Taxidermy art movement, or alternately, the Taxidermy Art movement. Apart from describing a genre of fine art, the term "rogue taxidermy" has expanded in recent years and has also become an adjective applied to unorthodox forms of traditional taxidermy such as anthropomorphic mounts and composite mounts where two or more animals are spliced together. (e.g.; sideshow gaffs of conjoined "freak" animals and mounts of jackalopes or other fictional creatures) In addition to being the impetus for the art movement, the inception of the genre also marked a resurgence of interest in conventional (traditional) forms of taxidermy.
Sources: en.wikipedia.org
=== Medically-induced coma === In addition to anesthesia induction, sodium thiopental was historically used to induce medical comas. It has now been superseded by drugs such as propofol because their effects wear off more quickly than thiopental. Patients with brain swelling, causing elevation of intracranial pressure, either secondary to trauma or following surgery, may benefit from this drug. Sodium thiopental, and the barbiturate class of drugs, decrease neuronal activity thereby decreasing cerebral metabolic rate of oxygen consumption (CMRO2), thus decreasing the cerebrovascular response to carbon dioxide, which in turn decreases intracranial pressure. Patients with refractory elevated intracranial pressure (RICH) due to traumatic brain injury (TBI) may have improved long term outcome when barbiturate coma is added to their neurointensive care treatment. Reportedly, thiopental has been shown to be superior to pentobarbital in reducing intracranial pressure. This phenomenon is also called an inverse steal or Robin Hood effect as cerebral perfusion to all parts of the brain is reduced (due to the decreased cerebrovascular response to carbon dioxide) allowing optimal perfusion to ischaemic areas of the brain which have higher metabolic demands, since vessels supplying ischaemic areas of the brain would already be maximally dilated because of the metabolic demand.
Motilin is a 22-amino acid polypeptide hormone in the motilin family that, in humans, is encoded by the MLN gene. Motilin is secreted by endocrine Mo cells (also referred to as M cells, which are not the same as the M cells, or microfold cells, found in Peyer's patches) that are numerous in crypts of the small intestine, especially in the duodenum and jejunum. It is released into the general circulation in humans at about 100-min intervals during the inter-digestive state and is the most important factor in controlling the inter-digestive migrating contractions; and it also stimulates endogenous release of the endocrine pancreas. Based on amino acid sequence, motilin is unrelated to other hormones. Because of its ability to stimulate gastric activity, it was named "motilin." Apart from in humans, the motilin receptor has been identified in the gastrointestinal tracts of pigs, rats, cows, and cats, and in the central nervous system of rabbits.
Other commonly used nanoparticle drug delivery systems include niosomes, liposomes, and vesosomes, the compositions of which contribute to different properties of the resulting nanoparticle compared to aquasomes. Niosomes are composed of non-ionic surfactants and bilayer structures, allowing them to encapsulate hydrophilic and hydrophobic drugs. Liposomes are composed of phospholipids and a similar bilayer structure to niosomes, and can deliver toxic or poorly soluble drugs. Vesosomes have a core-shell structure similar to aquasomes, but contain a lipid bilayer core and a polymer shell, while aquasomes consist of a ceramic or polymeric core and a carbohydrate coat. Vesosomes are used for encapsulating imaging agents and aiding in imaging techniques such as MRI.
== Key applications == Toxicity assessment/toxicology by metabolic profiling (especially of urine or blood plasma samples) detects the physiological changes caused by toxic insult of a chemical (or mixture of chemicals). In many cases, the observed changes can be related to specific syndromes, e.g. a specific lesion in liver or kidney. This is of particular relevance to pharmaceutical companies wanting to test the toxicity of potential drug candidates: if a compound can be eliminated before it reaches clinical trials on the grounds of adverse toxicity, it saves the enormous expense of the trials. For functional genomics, metabolomics can be an excellent tool for determining the phenotype caused by a genetic manipulation, such as gene deletion or insertion. Sometimes this can be a sufficient goal in itself—for instance, to detect any phenotypic changes in a genetically modified plant intended for human or animal consumption. More exciting is the prospect of predicting the function of unknown genes by comparison with the metabolic perturbations caused by deletion/insertion of known genes. Such advances are most likely to come from model organisms such as Saccharomyces cerevisiae and Arabidopsis thaliana. The Cravatt laboratory at the Scripps Research Institute has recently applied this technology to mammalian systems, identifying the N-acyltaurines as previously uncharacterized endogenous substrates for the enzyme fatty acid amide hydrolase (FAAH) and the monoalkylglycerol ethers (MAGEs) as endogenous substrates for the uncharacterized hydrolase KIAA1363.
=== Indolin derivatives === Indolin derivatives on the market are Sunitinib and Intedanib. Two indol derivatives that target the VEGF pathway, semaxanib and sunitinib, have been developed. The former is potent but was inefficient in clinical trials and the latter has many side effects. There is need for a drug with pharmacological effects similar to semaxanib and sunitinib, but it needs to be less toxic. MPEG3-9-semaxanib is semaxanib with an additional water-soluble, non-peptidic oligomer attached to it via a spacer moiety. MPEG3-9-semaxanib derivatives are 10 times more active against VEGFR-2 than sunitinib. Compounds with sunitinib heterocyclic moiety but different amide side chains inhibit VEGFR-1 and VEGFR-2 and regulate disorders. Another compound with sunitinib heterocyclic moiety and a pyrrole side chain has very good VEGFR-2 potency, with an IC50 of 65 nM. N-indol-1-amide compound is a possible anti-tumor drug in combination with other anticancer treatment and has an IC50 value of 31 nM. There are many indol derivatives with different side chains that target multiple kinases and take part in several pathways in tumor development. Intedanib is a multiple tyrosine kinase inhibitor and is the first drug to treat idiopathic pulmonary fibrosis. Indol derivatives with 1-NH of 2-indolinone motif that is an H-bond donor, and 2-carbonyl oxygen that acts as an H-bond acceptor, bind with Glu915 and Cys917, respectively. These compounds have basic amine side chains or nitrogen heterocycles and provide ideal solubility and pharmacokinetics.
Sources: en.wikipedia.org
== Physiological roles == Myo-Inositol plays an important role as the structural basis for a number of secondary messengers in eukaryotic cells, the various inositol phosphates. Glycosylated inositol phosphates (or inositol phosphate glycans, IPGs) are produced by cells exposed to insulin and mediate a range of its blood glucose-regulating outcomes. Inositol also serves as an important component of the structural lipids phosphatidylinositol (PI) and its various phosphates, the phosphatidylinositol phosphate (PIP) lipids. Glycophosphatidylinositol (or GPI), a glycosylated derivative of phosphatidylinositol formed with the sugar nucleotide UDP-GalNAc and the fatty acids palmitate or myristate, provides the anchor to which many peripheral membrane proteins are attached to cell membranes, defining the category GPI-anchored proteins.
== Endocrine system == Adrenocortical adenoma Adrenocortical carcinoma Carcinoid Gastrinoma Glucagonoma Insulinoma Islet cell carcinoma (endocrine pancreas) Merkel cell carcinoma Multiple endocrine neoplasia syndrome Pancreatic cancer Parathyroid cancer Pheochromocytoma Somatostatinoma Thyroid cancer VIPoma
=== Biosynthesis of cysteine === Mammals biosynthesize the amino acid cysteine via homocysteine. Cystathionine β-synthase catalyses the condensation of homocysteine and serine to give cystathionine. This reaction uses Pyridoxal phosphate (vitamin B6) as a cofactor. Cystathionine γ-lyase then converts this double amino acid to cysteine, ammonia, and α-ketobutyrate. Bacteria and plants rely on a different pathway to produce cysteine, relying on O-acetylserine.
Towards this end it sacrifices all, including the interests of the most revolutionary sections of the working class.” Here the CLP is referring to Lenin’s statement that the super-profits from the exploitation of the colonial peoples are used to bribe a sector of the working class in the imperialist country and turn this sector into an ally of the ruling class against the non-bribed sector of the working class. And further, "... the increasing economic crisis has forced the so-called "center” to the right and with it the CPUSA has moved to the right as well.”
== External links == Jane Higdon, "Vitamin A", Micronutrient Information Center, Linus Pauling Institute, Oregon State University NIH Office of Dietary Supplements – Vitamin A Vitamin A Deficiency at the Merck Manual of Diagnosis and Therapy
Sources: en.wikipedia.org
Common methods include protein determination, amino acid analysis, and molecular weight profiling by chromatography or electrophoresis. These tests describe composition and size distribution rather than a single active ingredient. Results can vary with the chosen method and laboratory standards.
Sealed dry powder is usually kept in a cool, dry place away from strong odors and moisture. Higher temperatures and humidity can cause clumping and quality loss. Manufacturers often specify a shelf life under unopened conditions.
Hydrolysis conditions and raw materials produce a range of peptide lengths rather than one uniform size. Analytical methods also give different averages depending on calibration and separation technique. Labels may therefore report a range or an average molecular weight.
Size-exclusion chromatography is the most common method, often calibrated with protein standards of known molecular weight. Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) can provide a visual profile. Mass spectrometry is used for detailed peptide sequencing.